KEGG   DRUG: Empagliflozin - linagliptin mixtHelp
Entry
D10588            Mixture   Drug                                   

Name
Empagliflozin - linagliptin mixt;
GlyXambi (TN)
Product
Component
Empagliflozin [DR:D10459], Linagliptin [DR:D09566]
Remark
Therapeutic category: 3969
ATC code: A10BD19
Product: D10588<JP/US>
Efficacy
Antidiabetic
  Disease
Type 2 diabetes mellitus [DS:H00409]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BD Combinations of oral blood glucose lowering drugs
     A10BD19 Linagliptin and empagliflozin
      D10588  Empagliflozin - linagliptin mixt <US>
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   396  Antidiabetic agents
    3969  Others
     D10588  Empagliflozin - linagliptin mixt
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10588
BRITE hierarchy
Other DBs
PubChem: 254741550
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system